1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Platinum based Cancer Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Cisplatin 1.2.3 Oxaliplatin 1.2.4 Carboplatin 1.2.5 Others 1.3 Market by Application 1.3.1 Global Platinum based Cancer Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Colorectal Cancer 1.3.3 Ovarian Cancer 1.3.4 Lung Cancer 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Platinum based Cancer Drug Market Perspective (2016-2027) 2.2 Platinum based Cancer Drug Growth Trends by Regions 2.2.1 Platinum based Cancer Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Platinum based Cancer Drug Historic Market Share by Regions (2016-2021) 2.2.3 Platinum based Cancer Drug Forecasted Market Size by Regions (2022-2027) 2.3 Platinum based Cancer Drug Industry Dynamic 2.3.1 Platinum based Cancer Drug Market Trends 2.3.2 Platinum based Cancer Drug Market Drivers 2.3.3 Platinum based Cancer Drug Market Challenges 2.3.4 Platinum based Cancer Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Platinum based Cancer Drug Players by Revenue 3.1.1 Global Top Platinum based Cancer Drug Players by Revenue (2016-2021) 3.1.2 Global Platinum based Cancer Drug Revenue Market Share by Players (2016-2021) 3.2 Global Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Platinum based Cancer Drug Revenue 3.4 Global Platinum based Cancer Drug Market Concentration Ratio 3.4.1 Global Platinum based Cancer Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Platinum based Cancer Drug Revenue in 2020 3.5 Platinum based Cancer Drug Key Players Head office and Area Served 3.6 Key Players Platinum based Cancer Drug Product Solution and Service 3.7 Date of Enter into Platinum based Cancer Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Platinum based Cancer Drug Breakdown Data by Type 4.1 Global Platinum based Cancer Drug Historic Market Size by Type (2016-2021) 4.2 Global Platinum based Cancer Drug Forecasted Market Size by Type (2022-2027) 5 Platinum based Cancer Drug Breakdown Data by Application 5.1 Global Platinum based Cancer Drug Historic Market Size by Application (2016-2021) 5.2 Global Platinum based Cancer Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Platinum based Cancer Drug Market Size (2016-2027) 6.2 North America Platinum based Cancer Drug Market Size by Type 6.2.1 North America Platinum based Cancer Drug Market Size by Type (2016-2021) 6.2.2 North America Platinum based Cancer Drug Market Size by Type (2022-2027) 6.2.3 North America Platinum based Cancer Drug Market Size by Type (2016-2027) 6.3 North America Platinum based Cancer Drug Market Size by Application 6.3.1 North America Platinum based Cancer Drug Market Size by Application (2016-2021) 6.3.2 North America Platinum based Cancer Drug Market Size by Application (2022-2027) 6.3.3 North America Platinum based Cancer Drug Market Size by Application (2016-2027) 6.4 North America Platinum based Cancer Drug Market Size by Country 6.4.1 North America Platinum based Cancer Drug Market Size by Country (2016-2021) 6.4.2 North America Platinum based Cancer Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Platinum based Cancer Drug Market Size (2016-2027) 7.2 Europe Platinum based Cancer Drug Market Size by Type 7.2.1 Europe Platinum based Cancer Drug Market Size by Type (2016-2021) 7.2.2 Europe Platinum based Cancer Drug Market Size by Type (2022-2027) 7.2.3 Europe Platinum based Cancer Drug Market Size by Type (2016-2027) 7.3 Europe Platinum based Cancer Drug Market Size by Application 7.3.1 Europe Platinum based Cancer Drug Market Size by Application (2016-2021) 7.3.2 Europe Platinum based Cancer Drug Market Size by Application (2022-2027) 7.3.3 Europe Platinum based Cancer Drug Market Size by Application (2016-2027) 7.4 Europe Platinum based Cancer Drug Market Size by Country 7.4.1 Europe Platinum based Cancer Drug Market Size by Country (2016-2021) 7.4.2 Europe Platinum based Cancer Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Platinum based Cancer Drug Market Size (2016-2027) 8.2 Asia-Pacific Platinum based Cancer Drug Market Size by Type 8.2.1 Asia-Pacific Platinum based Cancer Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Platinum based Cancer Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Platinum based Cancer Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Platinum based Cancer Drug Market Size by Application 8.3.1 Asia-Pacific Platinum based Cancer Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Platinum based Cancer Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Platinum based Cancer Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Platinum based Cancer Drug Market Size by Region 8.4.1 Asia-Pacific Platinum based Cancer Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Platinum based Cancer Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Platinum based Cancer Drug Market Size (2016-2027) 9.2 Latin America Platinum based Cancer Drug Market Size by Type 9.2.1 Latin America Platinum based Cancer Drug Market Size by Type (2016-2021) 9.2.2 Latin America Platinum based Cancer Drug Market Size by Type (2022-2027) 9.2.3 Latin America Platinum based Cancer Drug Market Size by Type (2016-2027) 9.3 Latin America Platinum based Cancer Drug Market Size by Application 9.3.1 Latin America Platinum based Cancer Drug Market Size by Application (2016-2021) 9.3.2 Latin America Platinum based Cancer Drug Market Size by Application (2022-2027) 9.3.3 Latin America Platinum based Cancer Drug Market Size by Application (2016-2027) 9.4 Latin America Platinum based Cancer Drug Market Size by Country 9.4.1 Latin America Platinum based Cancer Drug Market Size by Country (2016-2021) 9.4.2 Latin America Platinum based Cancer Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Platinum based Cancer Drug Market Size (2016-2027) 10.2 Middle East & Africa Platinum based Cancer Drug Market Size by Type 10.2.1 Middle East & Africa Platinum based Cancer Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Platinum based Cancer Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Platinum based Cancer Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Platinum based Cancer Drug Market Size by Application 10.3.1 Middle East & Africa Platinum based Cancer Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Platinum based Cancer Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Platinum based Cancer Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Platinum based Cancer Drug Market Size by Country 10.4.1 Middle East & Africa Platinum based Cancer Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Platinum based Cancer Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Platinum based Cancer Drug Introduction 11.1.4 Sanofi Revenue in Platinum based Cancer Drug Business (2016-2021) 11.1.5 Sanofi Recent Development 11.2 Hengrui Medicine 11.2.1 Hengrui Medicine Company Details 11.2.2 Hengrui Medicine Business Overview 11.2.3 Hengrui Medicine Platinum based Cancer Drug Introduction 11.2.4 Hengrui Medicine Revenue in Platinum based Cancer Drug Business (2016-2021) 11.2.5 Hengrui Medicine Recent Development 11.3 ASK Pharma 11.3.1 ASK Pharma Company Details 11.3.2 ASK Pharma Business Overview 11.3.3 ASK Pharma Platinum based Cancer Drug Introduction 11.3.4 ASK Pharma Revenue in Platinum based Cancer Drug Business (2016-2021) 11.3.5 ASK Pharma Recent Development 11.4 Yi Bai Pharmaceutical 11.4.1 Yi Bai Pharmaceutical Company Details 11.4.2 Yi Bai Pharmaceutical Business Overview 11.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Introduction 11.4.4 Yi Bai Pharmaceutical Revenue in Platinum based Cancer Drug Business (2016-2021) 11.4.5 Yi Bai Pharmaceutical Recent Development 11.5 Qilu Pharmaceutical 11.5.1 Qilu Pharmaceutical Company Details 11.5.2 Qilu Pharmaceutical Business Overview 11.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Introduction 11.5.4 Qilu Pharmaceutical Revenue in Platinum based Cancer Drug Business (2016-2021) 11.5.5 Qilu Pharmaceutical Recent Development 11.6 Teva 11.6.1 Teva Company Details 11.6.2 Teva Business Overview 11.6.3 Teva Platinum based Cancer Drug Introduction 11.6.4 Teva Revenue in Platinum based Cancer Drug Business (2016-2021) 11.6.5 Teva Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Platinum based Cancer Drug Introduction 11.7.4 Pfizer Revenue in Platinum based Cancer Drug Business (2016-2021) 11.7.5 Pfizer Recent Development 11.8 Dr Reddy's Laboratories 11.8.1 Dr Reddy's Laboratories Company Details 11.8.2 Dr Reddy's Laboratories Business Overview 11.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Introduction 11.8.4 Dr Reddy's Laboratories Revenue in Platinum based Cancer Drug Business (2016-2021) 11.8.5 Dr Reddy's Laboratories Recent Development 11.9 Mylan 11.9.1 Mylan Company Details 11.9.2 Mylan Business Overview 11.9.3 Mylan Platinum based Cancer Drug Introduction 11.9.4 Mylan Revenue in Platinum based Cancer Drug Business (2016-2021) 11.9.5 Mylan Recent Development 11.10 Sun Pharma 11.10.1 Sun Pharma Company Details 11.10.2 Sun Pharma Business Overview 11.10.3 Sun Pharma Platinum based Cancer Drug Introduction 11.10.4 Sun Pharma Revenue in Platinum based Cancer Drug Business (2016-2021) 11.10.5 Sun Pharma Recent Development 11.11 Novartis 11.11.1 Novartis Company Details 11.11.2 Novartis Business Overview 11.11.3 Novartis Platinum based Cancer Drug Introduction 11.11.4 Novartis Revenue in Platinum based Cancer Drug Business (2016-2021) 11.11.5 Novartis Recent Development 11.12 Debiopharm 11.12.1 Debiopharm Company Details 11.12.2 Debiopharm Business Overview 11.12.3 Debiopharm Platinum based Cancer Drug Introduction 11.12.4 Debiopharm Revenue in Platinum based Cancer Drug Business (2016-2021) 11.12.5 Debiopharm Recent Development 11.13 Accord Healthcare 11.13.1 Accord Healthcare Company Details 11.13.2 Accord Healthcare Business Overview 11.13.3 Accord Healthcare Platinum based Cancer Drug Introduction 11.13.4 Accord Healthcare Revenue in Platinum based Cancer Drug Business (2016-2021) 11.13.5 Accord Healthcare Recent Development 11.14 SK Chemicals 11.14.1 SK Chemicals Company Details 11.14.2 SK Chemicals Business Overview 11.14.3 SK Chemicals Platinum based Cancer Drug Introduction 11.14.4 SK Chemicals Revenue in Platinum based Cancer Drug Business (2016-2021) 11.14.5 SK Chemicals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Platinum based Cancer Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Cisplatin Table 3. Key Players of Oxaliplatin Table 4. Key Players of Carboplatin Table 5. Key Players of Others Table 6. Global Platinum based Cancer Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Platinum based Cancer Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Platinum based Cancer Drug Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Platinum based Cancer Drug Market Share by Regions (2016-2021) Table 10. Global Platinum based Cancer Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Platinum based Cancer Drug Market Share by Regions (2022-2027) Table 12. Platinum based Cancer Drug Market Trends Table 13. Platinum based Cancer Drug Market Drivers Table 14. Platinum based Cancer Drug Market Challenges Table 15. Platinum based Cancer Drug Market Restraints Table 16. Global Platinum based Cancer Drug Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Platinum based Cancer Drug Market Share by Players (2016-2021) Table 18. Global Top Platinum based Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum based Cancer Drug as of 2020) Table 19. Ranking of Global Top Platinum based Cancer Drug Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Platinum based Cancer Drug Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Platinum based Cancer Drug Product Solution and Service Table 23. Date of Enter into Platinum based Cancer Drug Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Platinum based Cancer Drug Market Size by Type (2016-2021) (US$ Million) Table 26. Global Platinum based Cancer Drug Revenue Market Share by Type (2016-2021) Table 27. Global Platinum based Cancer Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Platinum based Cancer Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Platinum based Cancer Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Platinum based Cancer Drug Revenue Market Share by Application (2016-2021) Table 31. Global Platinum based Cancer Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Platinum based Cancer Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Platinum based Cancer Drug Market Size by Type (2016-2021) (US$ Million) Table 34. North America Platinum based Cancer Drug Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Platinum based Cancer Drug Market Size by Application (2016-2021) (US$ Million) Table 36. North America Platinum based Cancer Drug Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Platinum based Cancer Drug Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Platinum based Cancer Drug Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Platinum based Cancer Drug Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Platinum based Cancer Drug Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Platinum based Cancer Drug Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Platinum based Cancer Drug Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Platinum based Cancer Drug Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Platinum based Cancer Drug Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Platinum based Cancer Drug Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Platinum based Cancer Drug Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Platinum based Cancer Drug Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Platinum based Cancer Drug Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Platinum based Cancer Drug Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Platinum based Cancer Drug Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Platinum based Cancer Drug Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Platinum based Cancer Drug Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Platinum based Cancer Drug Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Platinum based Cancer Drug Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Platinum based Cancer Drug Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Platinum based Cancer Drug Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Platinum based Cancer Drug Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Platinum based Cancer Drug Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Platinum based Cancer Drug Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Platinum based Cancer Drug Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Platinum based Cancer Drug Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Platinum based Cancer Drug Market Size by Country (2022-2027) & (US$ Million) Table 63. Sanofi Company Details Table 64. Sanofi Business Overview Table 65. Sanofi Platinum based Cancer Drug Product Table 66. Sanofi Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 67. Sanofi Recent Development Table 68. Hengrui Medicine Company Details Table 69. Hengrui Medicine Business Overview Table 70. Hengrui Medicine Platinum based Cancer Drug Product Table 71. Hengrui Medicine Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 72. Hengrui Medicine Recent Development Table 73. ASK Pharma Company Details Table 74. ASK Pharma Business Overview Table 75. ASK Pharma Platinum based Cancer Drug Product Table 76. ASK Pharma Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 77. ASK Pharma Recent Development Table 78. Yi Bai Pharmaceutical Company Details Table 79. Yi Bai Pharmaceutical Business Overview Table 80. Yi Bai Pharmaceutical Platinum based Cancer Drug Product Table 81. Yi Bai Pharmaceutical Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 82. Yi Bai Pharmaceutical Recent Development Table 83. Qilu Pharmaceutical Company Details Table 84. Qilu Pharmaceutical Business Overview Table 85. Qilu Pharmaceutical Platinum based Cancer Drug Product Table 86. Qilu Pharmaceutical Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 87. Qilu Pharmaceutical Recent Development Table 88. Teva Company Details Table 89. Teva Business Overview Table 90. Teva Platinum based Cancer Drug Product Table 91. Teva Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 92. Teva Recent Development Table 93. Pfizer Company Details Table 94. Pfizer Business Overview Table 95. Pfizer Platinum based Cancer Drug Product Table 96. Pfizer Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 97. Pfizer Recent Development Table 98. Dr Reddy's Laboratories Company Details Table 99. Dr Reddy's Laboratories Business Overview Table 100. Dr Reddy's Laboratories Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 101. Dr Reddy's Laboratories Recent Development Table 102. Mylan Company Details Table 103. Mylan Business Overview Table 104. Mylan Platinum based Cancer Drug Product Table 105. Mylan Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 106. Mylan Recent Development Table 107. Sun Pharma Company Details Table 108. Sun Pharma Business Overview Table 109. Sun Pharma Platinum based Cancer Drug Product Table 110. Sun Pharma Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 111. Sun Pharma Recent Development Table 112. Novartis Company Details Table 113. Novartis Business Overview Table 114. Novartis Platinum based Cancer Drug Product Table 115. Novartis Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 116. Novartis Recent Development Table 117. Debiopharm Company Details Table 118. Debiopharm Business Overview Table 119. Debiopharm Platinum based Cancer Drug Product Table 120. Debiopharm Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 121. Debiopharm Recent Development Table 122. Accord Healthcare Company Details Table 123. Accord Healthcare Business Overview Table 124. Accord Healthcare Platinum based Cancer Drug Product Table 125. Accord Healthcare Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 126. Accord Healthcare Recent Development Table 127. SK Chemicals Company Details Table 128. SK Chemicals Business Overview Table 129. SK Chemicals Platinum based Cancer Drug Product Table 130. SK Chemicals Revenue in Platinum based Cancer Drug Business (2016-2021) & (US$ Million) Table 131. SK Chemicals Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global Platinum based Cancer Drug Market Share by Type: 2020 VS 2027 Figure 2. Cisplatin Features Figure 3. Oxaliplatin Features Figure 4. Carboplatin Features Figure 5. Others Features Figure 6. Global Platinum based Cancer Drug Market Share by Application: 2020 VS 2027 Figure 7. Colorectal Cancer Case Studies Figure 8. Ovarian Cancer Case Studies Figure 9. Lung Cancer Case Studies Figure 10. Others Case Studies Figure 11. Platinum based Cancer Drug Report Years Considered Figure 12. Global Platinum based Cancer Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Platinum based Cancer Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Platinum based Cancer Drug Market Share by Regions: 2020 VS 2027 Figure 15. Global Platinum based Cancer Drug Market Share by Regions (2022-2027) Figure 16. Global Platinum based Cancer Drug Market Share by Players in 2020 Figure 17. Global Top Platinum based Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum based Cancer Drug as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Platinum based Cancer Drug Revenue in 2020 Figure 19. Global Platinum based Cancer Drug Revenue Market Share by Type (2016-2021) Figure 20. Global Platinum based Cancer Drug Revenue Market Share by Type (2022-2027) Figure 21. North America Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Platinum based Cancer Drug Market Share by Type (2016-2027) Figure 23. North America Platinum based Cancer Drug Market Share by Application (2016-2027) Figure 24. North America Platinum based Cancer Drug Market Share by Country (2016-2027) Figure 25. United States Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Platinum based Cancer Drug Market Share by Type (2016-2027) Figure 29. Europe Platinum based Cancer Drug Market Share by Application (2016-2027) Figure 30. Europe Platinum based Cancer Drug Market Share by Country (2016-2027) Figure 31. Germany Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Platinum based Cancer Drug Market Share by Type (2016-2027) Figure 39. Asia-Pacific Platinum based Cancer Drug Market Share by Application (2016-2027) Figure 40. Asia-Pacific Platinum based Cancer Drug Market Share by Region (2016-2027) Figure 41. China Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Platinum based Cancer Drug Market Share by Type (2016-2027) Figure 49. Latin America Platinum based Cancer Drug Market Share by Application (2016-2027) Figure 50. Latin America Platinum based Cancer Drug Market Share by Country (2016-2027) Figure 51. Mexico Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Platinum based Cancer Drug Market Share by Type (2016-2027) Figure 55. Middle East & Africa Platinum based Cancer Drug Market Share by Application (2016-2027) Figure 56. Middle East & Africa Platinum based Cancer Drug Market Share by Country (2016-2027) Figure 57. Turkey Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Platinum based Cancer Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Sanofi Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 61. Hengrui Medicine Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 62. ASK Pharma Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 63. Yi Bai Pharmaceutical Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 64. Qilu Pharmaceutical Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 65. Teva Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 66. Pfizer Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 67. Dr Reddy's Laboratories Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 68. Mylan Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 69. Sun Pharma Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 70. Novartis Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 71. Debiopharm Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 72. Accord Healthcare Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 73. SK Chemicals Revenue Growth Rate in Platinum based Cancer Drug Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Sanofi Hengrui Medicine ASK Pharma Yi Bai Pharmaceutical Qilu Pharmaceutical Teva Pfizer Dr Reddy's Laboratories Mylan Sun Pharma Novartis Debiopharm Accord Healthcare SK Chemicals